ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

TSHA Taysha Gene Therapies Inc

2.53
0.15 (6.30%)
2024年5月10日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Taysha Gene Therapies Inc TSHA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.15 6.30% 2.53 08:46:46
始値 安値 高値 終値 前日終値
2.39 2.31 2.56 2.53 2.38
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0805:05GLOBETaysha Gene Therapies to Release First Quarter 2024..
2024/5/0405:05GLOBETaysha Gene Therapies Announces Inducement Grant Under..
2024/5/0221:00GLOBETaysha Gene Therapies Announces Regenerative Medicine..
2024/4/0521:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
2024/3/2102:30APSAnother Biotech Steals The Show Following Major Clinical..
2024/3/2005:01GLOBETaysha Gene Therapies Reports Full Year 2023 Financial..
2024/3/1920:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
2024/3/1505:26GLOBETaysha Gene Therapies to Release Full-Year 2023 Financial..
2024/3/0207:08GLOBETaysha Gene Therapies Announces Inducement Grant Under..
2024/2/2922:00GLOBETaysha Gene Therapies Announces Updates to TSHA-102 Clinical..
2024/2/1606:01GLOBETaysha Gene Therapies Provides Update on Deprioritized..
2024/2/1006:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0222:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
2024/1/2222:00GLOBETaysha Gene Therapies Announces Poster Presentation on..
2024/1/1022:06EDGAR2Form 8-K - Current report
2024/1/1022:00GLOBETaysha Gene Therapies Announces First Pediatric Patient..
2024/1/0522:00GLOBETaysha Gene Therapies Announces Inducement Grant Under..
2023/12/2106:21EDGAR2Form 8-K - Current report
2023/12/2106:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/1921:30PRNUSTrinity Capital Inc. Provides $40 Million Term Loan to..
2023/11/2922:00GLOBETaysha Gene Therapies Announces Expanded Eligibility in..
2023/11/1606:29EDGAR2Form 8-K - Current report
2023/11/1506:47EDGAR2Form 8-K - Current report
2023/11/1506:08GLOBETaysha Gene Therapies Reports Third Quarter 2023 Financial..
2023/11/0722:00GLOBETaysha Gene Therapies to Release Third Quarter 2023..
2023/11/0405:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0405:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/0205:02EDGAR2Form 8-K - Current report
2023/10/2421:00GLOBETaysha Gene Therapies Presents New Preclinical In-vitro Data..
2023/10/1021:00GLOBETaysha Gene Therapies Announces Two Poster Presentations on..
2023/10/0520:00EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/2621:08EDGAR2Form 8-K - Current report
2023/9/2621:00GLOBETaysha Gene Therapies Announces Second Patient Dosed with..
2023/9/2205:01EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/9/2005:52DJNTaysha Gene Therapies to End Development of TSHA-120 After..
2023/9/2005:09EDGAR2Form 8-K - Current report
2023/9/2005:01GLOBETaysha Gene Therapies Provides Update on TSHA-120 Program in..
2023/9/1205:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/9/1113:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/3105:02EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/2920:00EDGAR2Form 8-K - Current report
2023/8/2605:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/8/2421:52DJNTaysha Gets FDA Fast-Track for Rett Syndrome Treatment
2023/8/2421:09EDGAR2Form 8-K - Current report
2023/8/2421:00GLOBETaysha Gene Therapies Announces Fast Track Designation..
2023/8/1421:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1420:29EDGAR2Form 8-K - Current report
2023/8/1420:02GLOBETaysha Gene Therapies Reports Initial Clinical Data from..
2023/8/1420:00GLOBETaysha Gene Therapies Announces $150 Million Private..
2023/8/0505:02EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock